YJR096W Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to YJR096W and Its Antibody

YJR096W encodes a putative oxidoreductase enzyme in S. cerevisiae, classified under the AKR6 family . While its exact biological role remains uncharacterized, homology studies suggest evolutionary links to stress-response pathways and redox regulation . The YJR096W antibody (e.g., MBS7159222) is a rabbit-derived polyclonal antibody designed to detect this protein in experimental assays .

Protein Features

  • Molecular Weight: 32,344 Da .

  • Domains: Shares structural homology with AKR enzymes, including a conserved (α/β)8 barrel fold and catalytic residues .

  • Post-Translational Modifications: Potential redox-active sites inferred from AKR family traits .

Antibody Characteristics

PropertyDetail
Host SpeciesRabbit
ReactivitiesSaccharomyces cerevisiae (strain S288c)
ApplicationsELISA, Western Blot (validated for antigen identification)
ImmunogenRecombinant YJR096W protein
PurityAntigen-affinity purified

Key Studies

  • Proteomic Profiling: YJR096W-tFT (tagged fluorescent timer) strains were used in ubiquitin-proteasome system studies, demonstrating stable expression and reproducibility in high-throughput screens .

  • Structural Analysis: The AKR6 family’s “hammerhead-like” loop structure (residues 245–270) in YJR096W suggests potential ligand-binding or regulatory roles, though functional validation is pending .

Limitations

  • Uncharacterized Function: YJR096W’s precise enzymatic activity and substrates remain unknown .

  • Cross-Reactivity Risks: Homology to human zinc finger proteins (e.g., MYM4) necessitates rigorous validation in cross-species studies .

Technical Considerations

  • Storage: Stable at -20°C or -80°C; brief centrifugation recommended to recover aliquots trapped in vial seals .

  • Experimental Optimization: Use strain-specific controls (e.g., S288c) to avoid false positives in yeast studies .

Future Directions

  • Functional Annotation: High-priority need for substrate identification and knockout phenotype analysis.

  • Therapeutic Potential: AKR enzymes are drug targets in metabolic diseases, positioning YJR096W as a candidate for inhibitor screening .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YJR096W antibody; J1926 antibody; Uncharacterized oxidoreductase YJR096W antibody; EC 1.-.-.- antibody
Target Names
YJR096W
Uniprot No.

Q&A

What is YJR096W and why are antibodies against it useful in research?

YJR096W is a protein in Saccharomyces cerevisiae (baker's yeast) that has been used in studies of the ubiquitin-proteasome system. Antibodies against YJR096W are particularly useful in protein turnover studies as the protein has shown reproducible detection patterns across multiple experimental iterations . When working with YJR096W antibodies, researchers should:

  • Validate antibody specificity using appropriate controls, including knockout strains if available

  • Consider the protein's natural expression levels when designing experiments

  • Determine optimal antibody concentrations through titration experiments

  • Be aware that YJR096W has been successfully used as a control in multiple screening experiments, showing high reproducibility

What sample preparation methods are most effective when using YJR096W antibodies for Western blotting?

When preparing yeast samples for Western blotting with YJR096W antibodies, researchers should consider the following protocol based on established methods:

  • Prepare yeast cell lysates using trichloroacetic acid (TCA) precipitation as described in previous studies

  • Alternatively, for mass spectrometry analysis, suspend cell pellets in urea buffer (8 M urea, 100 mM Tris⋅HCl, pH 8.0, 10 mM iodoacetamide)

  • Disrupt cells using 0.5-mm glass beads with shaking for approximately 25 minutes at room temperature

  • Clear lysates by centrifugation before proceeding with protein analysis

  • Resolve proteins via SDS/PAGE and transfer to nitrocellulose or PVDF membranes

  • Block membranes appropriately before incubating with YJR096W antibodies

This approach has been shown to effectively preserve protein integrity while minimizing degradation during sample preparation .

How should researchers validate the specificity of YJR096W antibodies?

Antibody validation is critical for ensuring experimental reproducibility. For YJR096W antibodies, consider these validation approaches:

  • Western blot analysis: Compare wild-type strains with YJR096W deletion mutants to confirm absence of signal in knockout strains

  • Immunoprecipitation followed by mass spectrometry: Verify that YJR096W is the predominant protein pulled down

  • Epitope tagging: Compare detection patterns between antibodies against the native protein and epitope-tagged versions

  • Cross-reactivity testing: Examine potential cross-reactivity with related yeast proteins

According to experimental practices described in the literature, antibodies should be validated using at least two independent methods before being used in critical experiments .

How can YJR096W antibodies be utilized in fluorescence-based proteasome activity assays?

YJR096W antibodies can be integrated into fluorescence-based proteasome activity assays using the following methodology:

  • Lyse cells in 0.3% CHAPS buffer (20 mM Hepes, 100 mM NaCl, 1 mM EDTA, 1.5 mM MgCl₂, 0.3% CHAPS, 1 mM DTT, 2.5 mM ATP, and protease inhibitor mixture)

  • Immobilize proteasomes onto agarose beads with bound anti-α6 antibodies

  • Include YJR096W antibody detection as a control measure for non-specific protein degradation

  • Wash beads twice with 0.03% CHAPS buffer

  • Incubate proteasomes at 37°C for 30 min with Suc-LLVY-AMC in reaction buffer (40 mM Tris⋅HCl, pH 7.2, 2 mM DTT, 5 mM MgCl₂, 10 mM creatine phosphate, 0.1 mg/mL creatine phosphate kinase, 5 mM ATP)

  • Stop reaction by adding 1% SDS and measure fluorescence at excitation 360 nm/emission 460 nm

This approach allows researchers to correlate proteasome activity with YJR096W protein levels, providing insights into the relationship between this protein and the UPS machinery.

What are the considerations when using YJR096W antibodies in timer-based proteomic profiling experiments?

Timer-based proteomic profiling with YJR096W antibodies requires careful experimental design:

  • Construct selection: When using YJR096W-tFT constructs as controls, ensure they are screened multiple times (24 times has shown reproducible results in previous studies)

  • Data normalization: Establish baseline stability measurements for YJR096W in wild-type cells before comparing mutant phenotypes

  • Statistical analysis: Apply appropriate statistical methods to detect significant changes in protein abundance or stability

ParameterWild-type cellsUPS mutant cellsStatistical significance
Protein abundanceBaseline valuesPotential changesp < 0.05 indicates significant change
Protein stabilityBaseline mCherry/sfGFP ratioAltered mCherry/sfGFP ratiop < 0.05 indicates significant change
Detection frequency~4.5% of mutant-tFT pairs show significant changes Varies by mutantCompare to global average
  • Result interpretation: Consider that proteins stabilized in UPS mutant screens are typically less stable in wild-type cells

  • Control selection: Include both stabilized controls (e.g., UBI4-tFT in Ubr1 deletion strains) and random controls (e.g., YJR096W-tFT) to validate experimental consistency

How can researchers investigate the relationship between YJR096W and the N-degron pathways using specific antibodies?

To study YJR096W in relation to N-degron pathways, researchers should:

  • Design targeted experiments: Create experimental setups comparing YJR096W stability in wild-type cells versus cells lacking components of the Arg/N-degron or Pro/N-degron pathways

  • Study potential N-terminal modifications: Analyze whether YJR096W contains N-terminal residues that might function as degrons

  • Investigate E3 ligase interactions: Test for interactions between YJR096W and E3 ligases involved in N-degron pathways, such as Ubr1 (Arg/N-degron pathway) or the GID complex (Pro/N-degron pathway)

  • Use comparative approaches: Compare YJR096W behavior with known substrates of these pathways

If YJR096W interacts with the N-degron pathway, researchers should observe stabilization patterns similar to those reported for other substrates, with evidence supporting direct physical interactions with pathway components .

How should researchers design experiments to study YJR096W protein turnover using antibodies?

When designing protein turnover experiments involving YJR096W antibodies, follow these key steps:

  • Define variables clearly:

    • Independent variable: Condition affecting protein stability (e.g., genetic mutation, treatment)

    • Dependent variable: YJR096W protein levels or turnover rate

    • Control for extraneous variables: Cell density, growth phase, temperature

  • Develop specific hypotheses:

    • Formulate testable predictions about YJR096W stability under specific conditions

    • Consider both abundance and turnover rate as separate experimental outcomes

  • Design appropriate treatments:

    • Include positive controls (known destabilizing conditions)

    • Include negative controls (conditions known not to affect stability)

    • Consider dose-response relationships when applicable

  • Select appropriate experimental approaches:

    • Cycloheximide chase for direct measurement of protein half-life

    • Fluorescent timer constructs for high-throughput stability assessment

    • Pulse-chase labeling for precise turnover determination

  • Plan measurement strategy:

    • Determine appropriate timepoints for sample collection

    • Select quantification methods (Western blotting, fluorescence measurement)

    • Establish robust normalization controls

What are the best practices for troubleshooting unexpected results when using YJR096W antibodies?

When encountering unexpected results with YJR096W antibodies, systematically address potential issues:

How can YJR096W antibodies be integrated into studies of the broader ubiquitin-proteasome system?

YJR096W antibodies can serve as valuable tools in comprehensive UPS studies:

  • Comparative stability profiling:

    • Use YJR096W as a reference protein when studying stability changes across UPS mutants

    • Compare turnover patterns with proteins of known degradation mechanisms

  • E3 ligase substrate identification:

    • Screen for stability changes in YJR096W across E3 ligase deletion libraries

    • Confirm direct interactions through co-immunoprecipitation studies

  • Proteasome activity correlation:

    • Relate YJR096W turnover rates to measured proteasome activities

    • Investigate whether YJR096W stability is sensitive to specific proteasome inhibitors

  • Integration with global datasets:

    • Correlate YJR096W behavior with genetic interaction profiles

    • Compare stability changes with protein-protein interaction networks

Research has shown that turnover and abundance interactions within the UPS frequently involve functionally related factors, with a significant degree of self-regulation observed within the system .

What immunofluorescence protocols are recommended when using YJR096W antibodies for subcellular localization studies?

For effective immunofluorescence using YJR096W antibodies, researchers should follow this optimized protocol:

  • Cell preparation:

    • Grow yeast to mid-log phase (OD₆₀₀ ~0.8-1.0)

    • Fix cells with 3.7% formaldehyde for 1 hour at room temperature

    • Wash cells in phosphate buffer with 1.2 M sorbitol

  • Cell wall digestion:

    • Treat with zymolyase (100 μg/ml) in phosphate buffer with 1.2 M sorbitol for 20-30 minutes

    • Monitor spheroplast formation microscopically

    • Wash gently to avoid cell lysis

  • Antibody staining:

    • Permeabilize cells with 0.1% Triton X-100 for 10 minutes

    • Block with 1% BSA in PBS for 30 minutes

    • Incubate with primary YJR096W antibody at optimized dilution (typically 1:100 to 1:500) overnight at 4°C

    • Wash thoroughly and incubate with fluorophore-conjugated secondary antibody for 1 hour

    • Counterstain nuclei with DAPI before mounting

  • Imaging considerations:

    • Use appropriate filter sets for the selected fluorophores

    • Consider co-staining with organelle markers for precise localization

    • Include controls for autofluorescence and non-specific binding

For advanced applications, fluorescence lifetime imaging microscopy (FLIM) can provide additional data on protein-protein interactions involving YJR096W .

How should researchers optimize YJR096W antibody-based co-immunoprecipitation protocols?

To maximize co-immunoprecipitation efficiency with YJR096W antibodies:

  • Lysis buffer optimization:

    • Test different lysis conditions (detergent types and concentrations)

    • For membrane-associated complexes, consider CHAPS (0.3%) or digitonin (1%)

    • Include protease inhibitors, phosphatase inhibitors, and deubiquitinase inhibitors as appropriate

  • Antibody coupling:

    • Covalently couple YJR096W antibodies to support matrix (e.g., Protein A/G beads)

    • Use chemical crosslinkers like dimethyl pimelimidate (DMP) for permanent attachment

    • Optimize antibody concentration for maximum protein capture while minimizing non-specific binding

  • Washing stringency balance:

    • Develop a washing protocol that preserves specific interactions while removing background

    • Consider detergent concentration, salt concentration, and number of washes

    • Test multiple conditions in parallel to determine optimal parameters

  • Elution strategies:

    • Compare different elution methods (pH, competitive elution, SDS)

    • For subsequent mass spectrometry analysis, avoid detergents incompatible with MS

  • Validation approaches:

    • Confirm interactions through reciprocal IPs where possible

    • Use tagged versions of YJR096W for validation

    • Compare results with known protein interaction datasets

What considerations are important when developing quantitative assays using YJR096W antibodies?

For quantitative applications of YJR096W antibodies:

  • Standard curve development:

    • Generate recombinant YJR096W protein standards of known concentration

    • Create standard curves covering the expected physiological range

    • Include standards in each experimental run

  • Assay optimization parameters:

    • Determine linear range of detection for both antibody concentration and protein amount

    • Optimize blocking conditions to minimize background without affecting specific signal

    • Validate reproducibility through technical and biological replicates

  • Normalization strategies:

    • Select appropriate loading controls (e.g., actin, tubulin)

    • Consider using total protein normalization methods

    • Validate normalization approach across experimental conditions

  • Data analysis approaches:

    • Apply appropriate statistical methods for quantitative comparisons

    • Consider transformations if necessary for normally distributed data

    • Report both absolute and relative quantification when possible

ParameterOptimization rangeValidation criteria
Antibody dilution1:500 - 1:5000Signal:noise ratio >10
Protein loading10-50 μg total proteinLinear response across range
Incubation time1-16 hoursMaximum signal with minimal background
Detection methodChemiluminescence, fluorescenceSensitivity and dynamic range

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.